SEC 13F Intelligence

Penderfund Capital Management Ltd. / ESPR

Penderfund Capital Management Ltd.’s Esperion Therapeutics Inc Ne Position

Does Penderfund Capital Management Ltd. own Esperion Therapeutics Inc Ne (ESPR)? Yes — 3.89M shares worth $11M (+1.67% of its 13F portfolio) as of Q1 2026, down from 4.39M shares the prior filed quarter.

Position Value
$11M
Q1 2026
Shares
3.89M
% of Portfolio
+1.67%
Quarters Held
5
currently held

Position History ESPR

Reported value by quarter
Q1 ’25: $4MQ1 ’25Q2 ’25: $11MQ2 ’25Q3 ’25: $18MQ3 ’25Q4 ’25: $16MQ4 ’25Q1 ’26: $11MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.89M$11M+1.67%
Q4 20254.39M$16M+2.56%
Q3 20256.68M$18M+2.98%
Q2 20252.00M$11M+2.94%
Q1 20252.00M$4M+0.81%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Penderfund Capital Management Ltd.’s full portfolio or all institutional holders of ESPR.